glp-1 asthma initiation was associated with a 14.6% reduced risk of exacerbation for overweight patients, 12.2% for obese patients and 13.3% for morbidly obese patients without diabetes, according to new research being The anti-inflammatory feature of glucagon-like

Common Reasons Why GLP-1 Treatment May Not Work Several factors can explain why GLP-1 medications may not produce the expected results for some individuals

As depicted in Figure 1 , several mechanisms mediated by uremic toxins underlie macrophage activation in CKD, leading to vascular inflammation: 1

The test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks and reporting carrier status

Ongoing provider communication is described as an essential protective measure

*Correspondence: Mara I